Holly Rosenfeld
DIR. MARKETING (THRU 2/20) at SEATTLE CANCER CARE ALLIANCE · WA · Healthcare
$251K
Peak Total Compensation
5
Years Tracked
3x
vs. Median Household
Holly Rosenfeld has appeared in compensation disclosures over 5 years of available data (2016–2020). Total compensation changed from $184,567 to $250,898 - a 35.9% increase.
Peak total compensation of $250,898 equals 3x the median U.S. household income ($75,000).
Compensation History
Year-by-Year Detail
| Year | Organization | Title | Compensation | Other | Total |
|---|---|---|---|---|---|
| 2020 | SEATTLE CANCER CARE ALLIANCE | DIR. MARKETING (THRU 2/20) | $198,066 | $52,832 | $250,898 |
| 2019 | SEATTLE CANCER CARE ALLIANCE | DIR. MARKETING | $197,271 | $42,224 | $239,495 |
| 2018 | SEATTLE CANCER CARE ALLIANCE | DIR. MARKETING | $183,795 | $38,761 | $222,556 |
| 2017 | SEATTLE CANCER CARE ALLIANCE | DIR. MARKETING | $176,181 | $38,257 | $214,438 |
| 2016 | SEATTLE CANCER CARE ALLIANCE | DIR. MARKETING | $162,069 | $22,498 | $184,567 |
Peers at SEATTLE CANCER CARE ALLIANCE
| Name | Title | Peak Comp. |
|---|---|---|
| Thomas J Lynch Md | PRESIDENT & DIRECTOR | $2.4M |
| Thomas Lynch | PRESIDENT & DIRECTOR | $2.0M |
| Nancy Davidson Md | EVP, CLINICAL AFFAIRS | $1.6M |
| Aaron Crane | FORMER OFF/CHIEF CLINICAL OP | $1.6M |
| Nicole C Robinson Phd | VP & COO | $1.3M |
| David Browdy | VP & CFO | $1.3M |
| Norman Hubbard | EXECUTIVE VP (THRU 4/19) | $1.2M |
| Sara Hurvitz Md | SVP & DIRECTOR, CLINICAL RESEARCH | $1.1M |
| Bruce E Clurman Md Phd | EVP, CHIEF SCI. OFFICER & DEPUTY DIRECTOR | $1.1M |
| Deborah Gentzen | VP, CHIEF STRATEGY OFC (THRU 5/20) | $1.0M |
Email Alerts
Get notified about Holly Rosenfeld
Get an email when a new IRS Form 990 filing is posted that includes this executive. We send a confirmation link first - we don't add you to any other list.
Compare with another executive: Open comparison tool →